Most Active Stocks

Alnylam Pharmaceuticals Up 4% on Positive Interim Results for Acute Hepatic Porphyria Drug

Alnylam Pharmaceuticals Up 4% on Positive Interim Results for Acute Hepatic Porphyria Drug

Alnylam Pharmaceuticals (ALNY) was out Thursday with positive topline results from the interim analysis of the ENVISION phase 3 study of givosiran, an investigational RNAi therapeutic targeting aminolevulinic acid synthase 1 (ALAS1) for the treatment of acute hepatic porphyria (AHP). The company said that results of the interim analysis showed that givosiran treatment was associated with a statistically significant reduction […]

WellCare Health Rises Pre-Bell After Disclosing Plans to Purchase Aetna’s Medicare Part D Prescription Business

WellCare Health Plans (WCG) said in a Form 8-K filing that it has signed an asset purchase agreement with Aetna, Inc. (AET) to acquire the latter’s entire standalone Medicare Part D prescription drug plan business, effective Dec. 31. Shares of WellCare climbed almost 2% in the pre-market. The unit had about 2.2 million members as of June 30, the filing […]

Salesforce Doesn’t Offer New Guidance at Investor Day, Benioff Speaks From the Heart

Salesforce Doesn’t Offer New Guidance at Investor Day, Benioff Speaks From the Heart

Salesforce (CRM) didn’t provide new guidance during its investor day, where the theme was “durable growth powered by competitive advantage,” but said it plans to provide guidance for calendar 2019 and fiscal 2020 in recent weeks, Wedbush analysts said in a note to clients Thursday morning. The new guidance likely will be during the company’s November third-quarter call and is […]

Canopy Growth Shares Rise 1% Pre-Bell After Shareholders OK $4 Bln Investment by Constellation Brands

Canopy Growth (CGC) shares rose in pre-market trading on Thursday, a day after shareholders of the diversified cannabis company approved the previously-announced C$5 billion ($4 billion) private placement of 104.5 million shares and 139.7 million share purchase warrants of the company to CBG Holdings, an affiliate of Constellation Brands (STZ). Of the 40.9% of common shares represented at the meeting, […]

Cellular Biomedicine Group and Novartis Partner to Bring CAR-T Cancer Therapy to China

Shares of Cellular Biomedicine Group (CBMG) have resumed pre-market activity after a brief halt following the company’s announcement Thursday that it has entered into a strategic licensing and collaboration agreement with Novartis (NVS) to manufacture and supply the CAR-T cell therapy Kymriah in China. Novartis will be the the exclusive holder of the marketing license. Under the terms of the […]

Newmark Group and BGC Partners to Monetize Nasdaq Share Positions

Newmark Group (NMRK), a commercial property services business, and its parent BGC Partners (BGCP) a brokerage and fintech company, Thursday reported that Newmark has entered into transactions related to the monetization of the shares of Nasdaq (NDAQ) it expects to receive in 2021 and 2022. Newmark said it expects cash proceeds of $113.2 million in Q3, due to its transaction […]